SK Basa’s decline reversed… ‘Bad Sang’ Failure (Comprehensive 2 Reports) | yunhap news

Transaction value of 2 trillion won… Some MTS jams in order runaway

SK Bioscience KOSPI New Listing Ceremony
SK Bioscience KOSPI New Listing Ceremony

[연합뉴스 자료사진]

(Seoul = Yonhap News) Reporter Kim A-Ram = SK Bioscience failed the upper limit march as it closed down on the 19th, the second day of listing.

In the securities market on this day, SK Biosciences finished trading at 166,000 won, down 1.48% from the previous day.

It rose by more than 10% at the beginning of the market, and then gradually narrowed as the profit-taking sales poured out. Eventually, it turned to a downtrend at the end of the market.

Based on the closing price, the market cap is about 12.7 trillion won, ranking 29th in the KOSPI (excluding preferred stocks).

Foreigners and institutions net sold 123.1 billion won and 29.7 billion won, respectively. However, among institutions, pension funds (201 billion won) and insurance (4 billion won) were the best to buy.

Individuals net bought 166.8 billion won and received the sale thrown by foreigners and institutions.

As of 3:30 pm, the trading volume is 12.17 million shares. The transaction amount is 2.17 trillion won, which is the number one in both KOSPI and KOSDAQ, and is about twice the size of Samsung Electronics (1.286 trillion won).

Mirae Asset Daewoo[006800] In some securities companies’ Mobile Trading System (MTS) apps, such as, there was a connection failure due to a surge in orders at the beginning of the market.

SK Biosciences, in particular, was in a situation where orders were crowded at once due to the large number of accounts that were allocated stocks in the public offering.

SK Bioscience, which has been regarded as an IPO in the first half of this year, previously made a record hit in the demand forecast of institutional investors and general subscription.

Following the enthusiasm for subscription, SK Bioscience jumped to 169,000 won, which doubled the public offer the day before and added an upper limit, and entered the stock market with a’dasang’.

The stocks available for distribution immediately after listing were 11.63% of the total issued stocks, which also had a significant impact on the amount released to the market.

The day before, the intraday contract amount was only 770,000 shares, but the remaining purchase amount reached 6.4 million shares.

However, it did not achieve the upper limit for two days in a row after listing, which had been highly anticipated by investors, so-called’tasangsang’.

[email protected]

Source